Delpharm

Overview

Delpharm is a leading Contract Development and Manufacturing Organization (CDMO) ranked in the top 5 globally, with an extensive network of 18 production sites across Europe and North America, 3 development centers, and approximately 6,500 employees. The company generated €1.1 billion in revenue and has over 35 years of experience supporting pharmaceutical partners through product development, technology transfer, and manufacturing.

Manufacturing Capabilities

Delpharm offers comprehensive expertise across multiple dosage forms:

Solid Dosage Forms: Tablets (sugar-coated, film-coated, effervescent), high-potent tablets, granules, powders, sachets, capsules, and pellets across multiple European and North American sites.

Semi-Solid Forms: Gels, creams, suppositories, and soft gel capsules, including high-potent formulations.

Liquid Formulations: Non-sterile solutions, syrups, oral suspensions, topical and nasal sprays, and high-potent liquids. Seven dedicated sites support liquid manufacturing with capacity to produce over 300 million units annually.

Sterile Injectable Products: Injectable ampules, suspensions, freeze-dried products, sterile powders in vials, impregnated dressings, aseptic eye drops, prefilled syringes, and complex microsphere injectables.

Specialized Expertise

Prefilled Syringes: State-of-the-art sterile facility integrating manufacturing, filling, automatic visual inspection, and secondary packaging, compliant with Annex 1 to ensure product quality and patient safety.

Nasal Sprays: Comprehensive manufacturing expertise with batch production ranging from 10 to 5,000 liters and filling of 3 to 100 ml glass or plastic bottles using automated lines and rigorous controls. Multiple sites (Montreal, Bladel, Huningue, Orléans) provide flexibility and diverse packaging options.

Liquid Pharmaceuticals: Seven specialized sites capable of supporting demanding pharmaceutical projects with bespoke support and flexible production scales.

Service Model

Delpharm emphasizes long-term partnerships with dedicated teams supporting product launch, technology transfer, and lifecycle management. The company prioritizes productivity, reactivity, and flexibility while maintaining rigorous quality standards. Manufacturing capabilities extend to licensed products, generics, OTC products, high-potent formulations, injectables, and veterinary products.